ArticleCancers2023
Differences in the Tumor Molecular and Microenvironmental Landscape between Early (Non-Metastatic) and De Novo Metastatic Primary Luminal Breast Tumors.
Yentl Lambrechts, Sigrid Hatse, François Richard, Bram Boeckx, Giuseppe Floris, Christine Desmedt, Ann Smeets, Patrick Neven, Diether Lambrechts, Hans Wildiers
Open access · goldAbstract read
In one paragraphArticle in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 56% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 2 institutions in 1 country.
Yentl LambrechtsLaboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-9013-8091 Sigrid HatseLaboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6764-2628 François RichardLaboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-4353-3619 Bram BoeckxLaboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.
Giuseppe FlorisLaboratory for Cell and Tissue Translational Research, Department of Imaging and Radiology, KU Leuven, 3000 Leuven, Belgium.
Christine DesmedtLaboratory for Translational Breast Cancer Research (LTBCR), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
Ann SmeetsDepartment of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, 3000 Leuven, Belgium.
Patrick NevenDepartment of General Medical Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1434-9460 Diether LambrechtsLaboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.
Hans WildiersLaboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-8990-7837 KU Leuven · BEVIB-KU Leuven Center for Cancer Biology · BE
Funding
Stichting tegen Kanker C/2020/1331
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast cancer biologyde novo–stage IV(luminal) breast cancermutationsprimary tumortumor microenvironment
Identifiers
PMID37686617
PMCPMC10486668
OpenAlexW4386285217
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390